Ownership Summary
Baird Medical Investment Holdings Ltd (NASDAQ:BDMD) has 8 institutional investors that have filed 13F reports for the period ending December 2025.
- They owned 2.0% of outstanding stock in December 2025, up from 1.7% the prior quarter.
- They increased total shares held in Baird Medical Investment Holdings by 36.43% from the prior quarter, while the number of investors in BDMD increased 14.29% year over year.
- Among the 8 funds, 3 bought more Baird Medical Investment Holdings shares, 1 sold down, and 4 held their ground.
- Altogether, these fund groups held 529.36K shares in BDMD by December 2025, up by 141.36K shares quarter on quarter, and up 223.86K shares year over year.
- HIGHBRIDGE CAPITAL MANAGEMENT LLC leads ownership in BDMD with 125.0K shares as of December 31, 2025, equal to 0.47% of outstanding shares.
- The largest buyers of Baird Medical Investment Holdings for the quarter ending December 2025 were TWO SIGMA INVESTMENTS, LP (95.44K), CITADEL ADVISORS LLC (66.13K), NATIONAL BANK OF CANADA /FI/ (11.7K).
- Top sellers of BDMD stock for the quarter ending December 2025 included UBS Group AG (31.91K).
- Business Quant data shows the 8 biggest positions in Baird Medical Investment Holdings as of December 2025 are held by HIGHBRIDGE CAPITAL MANAGEMENT LLC (125.0K), PERISCOPE CAPITAL INC. (125.0K), CITADEL ADVISORS LLC (112.66K), TWO SIGMA INVESTMENTS, LP (95.44K), UBS Group AG (33.91K), GEODE CAPITAL MANAGEMENT, LLC (25.44K), NATIONAL BANK OF CANADA /FI/ (11.7K), WOLVERINE ASSET MANAGEMENT LLC (205).